ZEB2 and prostate cancer: Simultaneous knockdown of both ZEB1 and ZEB2 expression establishes ZEB1 as a transcriptional repressor of E‐cadherin and a driver of docetaxel resistance in docetaxel‐resistant prostate cancer cells